Alere to Attend the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical Devices Conference on December 6, 2011

WALTHAM, Mass., Nov. 30, 2011 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical Devices Conference being held December 6, 2011 at the St. Regis, San Francisco.  Jon Russell, Vice President, Finance, will attend.  Mr. Russell's presentation is scheduled for Tuesday, December 6, 2011 at 11:40 PST.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home.  Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, toxicology and women's health.  Alere is headquartered in Waltham, Massachusetts.